Cargando…
C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer
T cell infiltration at the tumor site has been identified as a major predictor for the efficacy of adoptive T cell therapy. The chemokine C-C motif ligand 22 (CCL22) is highly expressed by immune cells in murine and human pancreatic cancer. Expression of its corresponding receptor, C-C chemokine rec...
Autores principales: | Rapp, Moritz, Grassmann, Simon, Chaloupka, Michael, Layritz, Patrick, Kruger, Stephan, Ormanns, Steffen, Rataj, Felicitas, Janssen, Klaus-Peter, Endres, Stefan, Anz, David, Kobold, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859768/ https://www.ncbi.nlm.nih.gov/pubmed/27195186 http://dx.doi.org/10.1080/2162402X.2015.1105428 |
Ejemplares similares
-
PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma
por: Rataj, Felicitas, et al.
Publicado: (2018) -
T cells armed with the C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
por: Lesch, Stefanie, et al.
Publicado: (2021) -
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models
por: Lesch, Stefanie, et al.
Publicado: (2022) -
S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
por: Grassmann, S, et al.
Publicado: (2014) -
Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
por: Kobold, Sebastian, et al.
Publicado: (2018)